Skip to Content

Notice

Issuer Delisting; Notice of Application of Applera Corporation To Withdraw Its Applera Corporation-Applied Biosystems Group Common Stock $.01 Par Value, Together With Rights To Purchase Series A Participating Junior Preferred Stock, $.01 Par Value, and Applera Corporation-Celera Genomics Group Common Stock, $.01 Par Value, Together With Rights To Purchase Series B Participating Junior Preferred Stock, $.01 Par Value, From Listing and Registration on the Pacific Exchange, Inc. File No. 1-04389

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble December 1, 2005.

On November 14, 2005, Applera Corporation, a Delaware corporation (“Issuer”), filed an application with the Securities and Exchange Commission (“Commission”), pursuant to section 12(d) of the Securities Exchange Act of 1934 (“Act”)[1] and Rule 12d2-2(d) thereunder,[2] to withdraw its Applera Corporation-Applied Biosystems Group common stock $.01 par value, together with rights to purchase series A participating junior preferred stock, $.01 par value, and Applera Corporation-Celera Genomics Group common stock, $.01 par value, together with rights to purchase series B participating junior preferred stock, $.01 par value (collectively “Securities”), from listing and registration on the Pacific Exchange, Inc. (“PCX”).

The Board of Directors (“Board”) of the Issuer approved a resolution on June 16, 2005 to withdraw the Securities from PCX. The Issuer stated that the Board determined that it is in the best interest of the Issuer and its stockholders to withdraw the Securities from PCX to avoid the direct and indirect costs associated with the listing of the Securities on PCX since the Securities are listed and traded on the New York Stock Exchange, Inc. (“NYSE”).

The Issuer stated in its application that it has complied with applicable rules of PCX by providing PCX with the required documents governing the withdrawal of securities from listing and registration on PCX. The Issuer's application relates solely to the withdrawal of the Securities from listing on PCX and shall not affect its continued listing on NYSE or its obligation to be registered under section 12(b) of the Act.[3]

Any interested person may, on or before December 23, 2005, comment on the facts bearing upon whether the application has been made in accordance with the rules of PCX, and what terms, if any, should be imposed by the Commission for the protection of investors. All comment letters may be submitted by either of the following methods:

Electronic Comments

Paper Comments

  • Send paper comments in triplicate to Jonathan G. Katz, Secretary, Securities and Exchange Commission, 100 F Street, NE.,Washington, DC 20549-9303.

All submissions should refer to File Number 1-04389. This file number should be included on the subject line if e-mail is used. To help us process and review your comments more efficiently, please use only one method. The Commission will post all comments on the Commission's Internet Web site (http://www.sec.gov/​rules/​delist.shtml). Comments are also available for public inspection and copying in the Commission's Public Reference Room. All comments received will be posted without change; we do not edit personal identifying information from submissions. You should submit only information that you wish to make available publicly.Start Printed Page 72866

The Commission, based on the information submitted to it, will issue an order granting the application after the date mentioned above, unless the Commission determines to order a hearing on the matter.

Start Signature

For the Commission, by the Division of Market Regulation, pursuant to delegated authority.4

Jonathan G. Katz,

Secretary.

End Signature End Preamble

Footnotes

[FR Doc. E5-6982 Filed 12-6-05; 8:45 am]

BILLING CODE 8010-01-P